Founded in 2021, Biodimension Technology operates in Health Tech offering biofabricated human tissues as an efficient animal alternative for testing solutions to pharmaceutical companies. The company ...
Funding stage:
Undisclosed
Last funding:
10/06/2026
Total funding:
$984.98K+
Revenue:
Investors
Employee count:
20
Last 90d
20
Last 90d
Web traffic:
688
688
Last 30d
Last 30d
Biodimension Technology: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders4
Latest Filing Date30 March 2024- Funding Events1
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Biodimension Technology
As of 31 March 2024, Biodimension Technology's equity is held by 4 shareholders, with the top three being Vit Tbi, Arunachalam Pradeep, and Ranjithkumar Velusamy.
Vit Tbi holds the largest stake in Biodimension Technology at 97.6% as of 31 March 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links